Skip to content
OpenCapital
Get started

Anika Therapeutics ANIK Increase (Decrease) in Inventories

Increase (Decrease) in Inventories at other companies

AVN
AVNSAVNS
-$6.1M-408%
Globus Medical logo
Globus MedicalGMED
——
Envista Holdings Corporation logo
Envista Holdings CorporationNVST
——

Other financials

Income statement

See full
Revenue$32.6M+15.6%
Net income$3.3M+183%
EPS (diluted)$0.24—

Balance sheet

See full
Cash & equivalents$38.4M-27.8%
Total debt$25.7M+1.2%
Total equity$137.3M-7.0%
Total assets$183.5M-2.2%

Cash flow

See full
Operating cash flow-$684.0K-262%
CapEx$1.4M-1.2%
Free cash flow-$2.1M-28.8%

Valuation

See full
Market cap$199.85M+23.0%
P/S1.7×-0.1×

Profitability

See full
Net margin-3.4%-1.6pp
FCF margin0.5%—

Returns & leverage

See full
Return on equity-2.9%-1.4pp
Debt / equity0.2×0.0×
Current ratio4.5×-1.7×

Where this comes from

Reported directly by Anika Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInInventories.

The official record: Anika Therapeutics’s 8-K, filed July 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Anika Therapeutics's increase (decrease) in inventories.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Anika Therapeutics's increase (decrease) in inventories?
Anika Therapeutics (ANIK) reported increase (decrease) in inventories of -$2.83M in Q2 2026.
How has Anika Therapeutics's increase (decrease) in inventories changed year-over-year?
Anika Therapeutics's increase (decrease) in inventories decreased by 63.8% year-over-year, from -$1.73M to -$2.83M.
What is the long-term trend for Anika Therapeutics's increase (decrease) in inventories?
Over 2 years (2021 to 2023), Anika Therapeutics's increase (decrease) in inventories has grown at a 26.5% compound annual growth rate (CAGR), from $7.12M to $11.4M.